Document Detail

Long-term evaluation of single bolus high dose ATG induction therapy for prophylaxis of rejection in live donor kidney transplantation.
MedLine Citation:
PMID:  17978857     Owner:  NLM     Status:  MEDLINE    
BACKGROUND/AIMS: The long-term evaluation of single bolus high dose antithymocyte globulin (ATG) induction therapy has not been adequately studied. We aimed to evaluate its long-term effects in the living related donor kidney transplantation. METHODS: Eighty adult recipients with their first kidney allograft were randomized into two equal treatment groups, one group received intraoperative single bolus rabbit ATG in a dose of 9 mg/kg and the second group served as a control. All patients were maintained on triple immunosuppressive therapy (steroids, calcineurin inhibitor and antiproliferative agent). We followed them thoroughly for minimum of 5 years. RESULTS: ATG significantly reduced the proportion of patients who experienced acute rejection episodes in the first year (9/40) when compared to the control group (26/40) and in 5 years (11/40) when compared to (30/40) in controls. The cumulative steroid dose used throughout the study was significantly lower in the ATG group. The overall incidence of posttransplant complications was comparable among the two treatment groups. There was no significant difference in patient and graft survival: 5 year survival was 100% and 85% for the ATG group, and 95% and 92.5% in the control group, respectively. CONCLUSION: Although routine single bolus ATG induction significantly reduces the incidence of acute rejection, its long-term beneficial effects on graft function and patient and graft survival are not evident.
Hussein A Sheashaa; Ahmed F Hamdy; Mohamed A Bakr; Sherif F Abdelbaset; Mohamed A Ghoneim
Related Documents :
11520757 - Steroid management in giant cell arteritis.
23635387 - Effect of timing of thrombectomy on survival of thrombosed arteriovenous hemodialysis g...
9921817 - Five cases of kaposi's sarcoma in kidney graft recipients: possible influence of the im...
23816417 - A meta-analysis of transcatheter aortic valve implantation versus surgical aortic valve...
22367567 - Appropriate therapies predict long-term mortality in primary and secondary prevention o...
1877437 - Long-term angiographic follow-up after angioplasty of venous coronary bypass grafts.
Publication Detail:
Type:  Journal Article; Randomized Controlled Trial    
Journal Detail:
Title:  International urology and nephrology     Volume:  40     ISSN:  0301-1623     ISO Abbreviation:  Int Urol Nephrol     Publication Date:  2008  
Date Detail:
Created Date:  2008-08-14     Completed Date:  2008-09-30     Revised Date:  -    
Medline Journal Info:
Nlm Unique ID:  0262521     Medline TA:  Int Urol Nephrol     Country:  Hungary    
Other Details:
Languages:  eng     Pagination:  515-20     Citation Subset:  IM    
Urology & Nephrology Center, Mansoura University, Mansoura, Egypt.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Antilymphocyte Serum / administration & dosage*
Glucocorticoids / administration & dosage
Graft Rejection / prevention & control*
Infusions, Intravenous
Kidney Transplantation / immunology*
Living Donors
Methylprednisolone / administration & dosage
Plasma Exchange
Prospective Studies
Reg. No./Substance:
0/Antilymphocyte Serum; 0/Glucocorticoids; 83-43-2/Methylprednisolone

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine

Previous Document:  Central venous catheters as a vascular access modality for pediatric hemodialysis.
Next Document:  Idiopathic infantile hypercalcemia and renal involvement.